Tiny biotechs are racking-up huge returns right now, as my subscribers can tell you. 

We've just witnessed 14 back-to-back triple-digit gainers in the last 60 days, and things show no sign of letting up.

That's why, as of this very moment, I'm telling my subscribers --- in no uncertain terms --- "Load-up the truck and buy shares in Global Health (GHLV:OTCBB) ... and get ready to QUADRUPLE  your money in the next 60 days."

Listen...

	It already happened to Candela Corp --- a tiny stock that went from $1.06 to $3.46 --- a 226% gain... in just six weeks.
	It happened again when Cel Sci Corp was trading for just $0.48... and then shot 338% higher one month later.
	And, don’t forget the biggest winner, Adeona Pharmaceuticals, which, in just five days, soared from $0.34 to $1.70... for a whopping 400% gain.

Hurry Up... The Smart Money’s Already Moving In

We're on the verge of seeing a mass frenzy sweep through the biotech sector, sending big stocks higher and tiny stocks through the roof. Why? 

Because savvy investors know, the greatest bull market of the 21st century isn't going to be oil.  Nor will it be housing... or agriculture... or even technology.

No, the greatest bull market of the coming decades is going to be in healthcare and biotech. And the “smart money” has already anticipated it, planned for it, and positioned for it.

The question is, Have you?

Listen, investors are buying up tiny biotechs like Discovery Laboratories, whose shares fetched a mere $0.47 on September 10th... and three weeks later hit $1.69 for a cool 260% gain.

Yes, my subscribers are thanking me for handing them unbelievable profits such as these.  And it’s no wonder... my biotech stock picks are simply going bananas.

I'm talking about stocks like Interleukin Genetics, which just ten days ago exploded 538%... overnight.  Investors QUINTUPLED their money --- as they slept.

And don't forget, Imaging3 Inc...

Back on September 1st the stock was trading for a mere $0.04. But then the "smart money" discovered it... 

Listen, there’s a massive boom happening in biotech stocks right now, and investors are already up several hundred percent in the last two months alone.

In fact, we’ve seen an average of one triple-digit gainer... every four days. 

My Readers Are Making A Killing In Biotech... RIGHT NOW

You’ve probably heard horror stories of how biotech companies routinely blow through $50 million as they go through an endless labyrinth of FDA procedures and bureaucratic hoops. Well, that’s not a problem with Global Health (GHLV).

You see, the geniuses behind GHLV aren't a bunch of ivory tower eggheads holed-up in a lab somewhere, trying to win a Nobel Prize.

No, they're a rare hybrid of “top-flight scientists and elite entrepreneurs”... and they’ve “cracked the code” for taking a company from zero to billions in value --- for pennies on the dollar.

In short, they know how to make investors rich. Seriously rich.

What's their secret?

Don't Re-invent The Wheel... Make it Better

Their strategy is to take multi-billion dollar drugs --- household names like Viagra --- that are about to go off-patent, and give them a different and more effective delivery system (think under the tongue).

This allows GHLV to lower the dose, turn the drugs into an over-the-counter variety... and take over the market in the process.

In short, they've figured out how to leapfrog the competition and capture massive profits... in months, not decades.

As I write this, Global Health (GHLV) is developing three flagship products that tap into some of the largest and most lucrative markets in the world.

Let me describe them to you...

Target #1: Beat Viagra At Its Own Game

Their showcase product is targeting the erectile dysfunction market... a $3 billion industry that’s growing at an extraordinary pace, thanks to our aging population. And Global Health (GHLV) is developing a specially formulated drug that’s more effective --- with fewer side effects --- than Viagra itself.

The drug is called "X-Excite". And it uses the same active ingredient as Viagra (sildenafil), so you know it's going to work.

But instead of the pill being swallowed, Global Health (GHLV) is utilizing their proprietary sublingual delivery platform.  And this is where “X-Excite” gets really interesting...

Going sublingual provides three MAJOR advantages over Viagra.

	One, the effects of X-Excite kick-in SIX-TIMES faster than its blue-pilled cousin (approximately 5 minutes after intake vs 30 minutes for Viagra).
	Two, the drug has far fewer side effects. You see, because you’re not swallowing a pill, there's no stomach or intestinal exposure. That means gastrointestinal side effects such as acidosis and diarrhea may well be completely eliminated.
	And three, because the dose is lower, the drug will be available at a lower cost.

All this adds up to a stunning triple-knockout:

Although X-Excite is in the final stages of testing, it’s being “fast-tracked” onto local pharmacy shelves. And when it goes retail --- watch out. This drug is going to take the erectile dysfunction market by storm.

The fact is, this amazing drug is enough to send shares in Global Health (GHLV) to the moon. But the company has two more products in development, either of which could send the stock into overdrive inside of the next 12 months.

Target #2: The Obesity Epidemic

As everyone is now aware, an obesity epidemic is sweeping across North America.

In fact, the Centers for Disease Control and Prevention estimates it’s already begun to affect two-thirds of the U.S. population.

More startling however, is that the World Health Organization reports one out of six people worldwide are now affected by the medical problem.

That's ONE BILLION PEOPLE.

Indeed, the market for anti-obesity products has enormous possibilities. Already the industry is raking-in an estimated $5 billion annually.

But the problem is, most of the people who go through intense forms of exercise and diet regain their weight within a few months of losing it.

It's a vicious, unhealthy cycle that drives individuals mad.

And that's where Global Health's anti-obesity drug "T-Slim" comes in.

“T-Slim” is an appetite-suppressant with a simple but amazing twist that allows it to work on a cellular level. A brand new formulation, this drug utilizes a specialized, all-natural antioxidant called catechin to reduce appetite and, over time, manage weight loss through controlling food intake.

And unlike some of the more prominent forms of weight control available today, T-Slim is needle-free and will be available over-the-counter.

It doesn’t take a rocket scientist to figure out... this drug could rake-in billions over the coming years...
Making GHLV investors hugely rich in the process.

But that's not all GHLV has up its sleeve.

The company has also identified another market that could blast your profits through the roof...  

Target #3: Cure Addiction

Global Health's next game-changer is aptly named "Nico-Z". That's because "Nico-Z" is a sublingual formulation of nicotine designed to help smokers quit.

This multi-billion dollar industry has plenty of competition... but almost all currently marketed products (patches, gums or sprays) suffer from two major drawbacks: they’re either very poorly absorbed by the body thus limiting their effectiveness, or they're inconvenient.

Nico-Z addresses both these issues by providing a super-high absorption efficiency AND being easy to use. Just pop Nico-Z under the tongue and almost instantly the drug hits the bloodstream.

Odds are, you or someone you know currently smokes, and would like to quit. In fact, it’s estimated that 60 million people in the US currently smoke.

And with more and more people trying to "kick the habit" everyday, this drug alone has the potential to propel the market-cap of GHLV through $500 million.

That translates into one thing for GHLV investors: “Cha-Ching.” The upside for Nico-Z is enormous.

Listen...

These industries are so enormous that if Global Health (GHLV) penetrates a mere fraction of just one percent, it will be enough to send its share price soaring.

And with drugs like "X-Excite" and "Nico-Z" --- which are superior to products currently on the market --- it’s easy to see this stock shooting through the stratosphere in the near-term.

That's why GHLV is an immediate "must-buy".
But you need to act quickly...

You see, the company is rapidly progressing along the path to commercialization (think months... not years), and if you don’t pick-up shares now --- while they’re cheap --- you will miss out. It’s no secret that a company with this much potential could easily...

Let me ask you something...

	Do you think Pfizer is going to stand idly by when “X-Excite” — a faster, safer, and all around better drug — takes the erectile dysfunction market by storm?
	Or how about Merck, Eli Lilly, or GlaxoSmithKline? Do you think they’ll just say "Aw shucks" as GHLV steals their sales with more effective versions of drugs it took years to develop?

Of course not.

They’re going to take-over GHLV and fast... handing investors massive windfall profits in the process.

But that’s not all...

There’s another reason this company is likely to get bought-out for a multiple of today’s share price...

Global Health (GHLV) has locked-up worldwide rights to a ground-breaking technology that could revolutionize the entire pharmaceutical industry... and I don't think that's sitting well with Big Pharma.

In fact, I’m betting Big Pharma is going to pay BIG to acquire the proprietary technology for themselves.

Why? Because if they don’t, Global Health (GHLV) is going to beat them at their own game.

And to rub salt in the wound, GHLV will do it by taking Big Pharma’s drugs that go off-patent --- the ones they spent hundreds of millions of dollars developing --- and making them more effective and safer, while selling them OTC for a lot less.

Think Big Pharma can ignore that scenario?

Listen, Pfizer has its back against the wall on this one. Either they take-out GHLV at a hefty premium... or they get beaten-up by “the little guy”.

Either way, my subscribers are going to win big.

But don't wait...

Proprietary Technology That's Got Big Pharma 'Drooling'

Global Health (GHLV) has developed a proprietary platform that delivers drugs in a better and more efficient manner than the industry standard.

In fact, the technology could eventually make "pill form" medication obsolete.

If that didn’t take your breath away then let me repeat...

This tiny stock --- with a market cap of just $50 million --- could revolutionize the entire health care industry... and do away with pill-form medication forever.

Stop and think what that will do to the share price for a second...

Without a doubt the stock would blow right past $50. I bet it would probably head well over $100 a share... making you outrageously wealthy in the process.

So how does the technology work?

As I alluded to earlier, it involves delivering the drugs “sublingually”, or under the tongue. This is advantageous for a number of reasons...

	It delivers drugs to the bloodstream faster so medicine is absorbed by the body quicker.
	It minimizes drug breakdown by bypassing the gastro-intestinal system.
	It reduces or eliminates all gastro-intestinal related side effects.
	It reduces drug manufacturing costs because the increased absorption rate requires a lower dosage.
	And, it increases the potential marketplace by making the drugs available over-the-counter.

Sounds pretty impressive, right? Well, the really stunning thing is GLHV's massive slingshot potential within a short 60 days....

Remember Interleukin Genetics? The stock catapulted 538% OVERNIGHT.

How about Helicos BioSciences? It exploded 321% in only 14 days.

And Imaging? You could have locked-in 1,750% profits in less than a month.

If you’d “waited” on any of these stocks, you’d have missed the boat... and left thousands of dollars on the table.

Don't "wait-and-see" with GHLV...

My time-tested system has determined this stock will scream higher in the next few days... multiply-in-value fourfold in the next two months... and catapult 10-times higher within a year.

But you must hurry because...

The Rocket Is About To Leave The Launch Pad

You get the picture?

I’ve already told you the biotech industry is red-hot... that tiny stocks are the place to be... and how investors like you are making a killing as company after company explodes in value.

Now I’m telling you Global Health (GHLV) is next.

This Stock Is A Lock For 400%+ Gains

• It’s targeting three of the most lucrative drug niches in the world: obesity, addiction, and erectile dysfunction.
   
• Its proprietary drug delivery platform is sending shock waves through the entire industry... and setting the stage for Global Health to get taken out at a HUGE premium.

And, it’s run by one of the most brilliant minds in biotech.

As an investor, this is the kind of situation you dream of.

Call your broker immediately and buy as many shares of Global Health (GHLV:OTCBB) as you can get your hands on.

Two months from now you could be taking your profits out by the truck load, and that’s when you’ll be thanking me for sending you this confidential alert.

But you must place your order right now. Not later. Right now.

The smart money is already piling in. They know Global Health is a grand slam. And they’re making sure they get in cheap, before the herd bids the stock out of reach.

Just like Interleukin Genetics, this stock could pop tomorrow... then shoot out of reach.

Don’t miss out.

Take a big position immediately. And don’t forget to take partial profits when the stock quadruples.

Sincerely,

Joe Marino
Editor, The Stock Profiteer

PS - After you place your buy order, you’ll need to stay on top of this stock. That's why you should lock-in your subscription to my monthly newsletter now (click here for a special discount offer).

PPS - I just put the finishing touches on a special version of this report.  Inside, I reveal more secrets that could multiply your profits 4-FOLD. 

It's completely free and you can download it here.